LCMS webinars focusing on LC/TOF - page 13

The best practices for untargeted feature finding, focusing on achieving the optimal balance between sample coverage and processing speed.

This online event has been designed for our customers and brings together opinion leaders, top scientists and industry innovators to share their research in the biopharma field.

In the seventh episode you will hear about fundamentals of MS in LC/MS, LC/MS/MS & TOF Systems.

Discover how to harness the power of quantitative analysis for effective screening and identification of potential suspect compounds.

A HTS proteomics approach that utilizes label-free, single-shot dia-PASEF® mass spectrometry to identify novel degrader targets on a large scale with unmatched coverage, accuracy, and speed.

We will explore the critical aspects of differentiating good from bad data and how this distinction can significantly influence your results.

Hear about the latest advancements in translational proteomics and metabolomics.

Hear about the latest advancements in translational proteomics and metabolomics.

Tissue sample processing, data acquisition with a Bruker timsTOF Ultra, and data analysis will be reviewed as tools for the development and validation of HLA peptide targets for immunopeptidomic development.

Alithea has a significant track record in the absolute quantification of HLA peptides, off-target toxicity predictions and target discovery.